Public Profile

Insulet

Insulet Corporation, commonly known for its innovative Omnipod® Insulin Management System, is a leading player in the diabetes care industry. Headquartered in the United States, Insulet operates primarily in North America and Europe, focusing on developing advanced insulin delivery solutions. Founded in 2000, the company has achieved significant milestones, including the launch of its tubeless insulin pump, which revolutionised diabetes management for many patients. Insulet's core product, the Omnipod, stands out due to its unique design that offers a wireless, waterproof, and discreet insulin delivery system. This innovative approach has positioned Insulet as a market leader, recognised for enhancing the quality of life for individuals with diabetes. With a commitment to continuous improvement and patient-centric solutions, Insulet remains at the forefront of diabetes technology, driving advancements that empower users to manage their condition effectively.

DitchCarbon Score

How does Insulet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

39

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Insulet's score of 39 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.

93%

Let us know if this data was useful to you

Insulet's reported carbon emissions

In 2023, Insulet reported total greenhouse gas emissions of approximately 5,000,000 kg CO2e, comprising 1,316,000 kg CO2e from Scope 1 and about 3,977,000 kg CO2e from Scope 2 emissions. This represents a continued commitment to reducing their carbon footprint, following a significant reduction in Scope 1 emissions of about 19% from 2020 to 2021. Insulet has set ambitious climate commitments, aiming for a net-zero transition by 2050. They are actively investing in renewable energy and have established targets for greenhouse gas emissions reduction across both Scope 1 and Scope 2 emissions. Their new manufacturing facility in Malaysia is on track to achieve Green Building Index (GBI) certification and Leadership in Energy and Environmental Design (LEED) Silver certification, further supporting their sustainability goals. The company is developing a comprehensive blueprint for achieving net-zero emissions by 2025, with specific initiatives aimed at enhancing energy efficiency and increasing the use of renewable energy sources. Insulet's ongoing efforts reflect a strong commitment to minimising their environmental impact while continuing to grow their operations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
1,709,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
3,761,000
0,000,000
0,000,000
0,000,000
00,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Insulet's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Insulet is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Insulet is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Medtronic MiniMed, Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Roche Diabetes Care, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

MicroTech Medical (Hangzhou) Co., Ltd.

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Zealand Pharma A/S

DK
Health and social work services (85)
Updated 1 day ago

embecta

US
Food waste for treatment: incineration
Updated 1 day ago

Ypsomed

CH
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers